Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C18H17N3O2 |
| Molecular Weight | 307.3465 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OC1=C(N2CCCC2)C(=O)N(C3=CC=CC=C3)C4=C1C=CC=N4
InChI
InChIKey=ULGABHCZIJXUFO-UHFFFAOYSA-N
InChI=1S/C18H17N3O2/c22-16-14-9-6-10-19-17(14)21(13-7-2-1-3-8-13)18(23)15(16)20-11-4-5-12-20/h1-3,6-10,22H,4-5,11-12H2
| Molecular Formula | C18H17N3O2 |
| Molecular Weight | 307.3465 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Pirodomast is Thromboxane A (TXA2) synthetase inhibitor. Pirodomast can inhibit leukotriene (LT) D4, C4, E4 formation and Thromboxane B2 (TXB2) activities. It was weak or ineffective as an antagonist of histamine, methacholine, serotonin, LTC4 or platelet activating factor induced bronchospasms in guinea pigs. Also, pirodomast was not a bronchodilator or calcium influx blocker and had only weak relaxant activity on guinea pig trachea in vitro. Pirodomast is, therefore, a potential antiallergic agent that inhibits leukotriene (LT) release. Pirodomast inhibited tryptase proteolytic activity in-vitro. In experimental studies in vivo, pirodomast blocked antigen-induced immediate and late asthmatic responses in allergic sheep. Pirodomast inhibited antigen-induced airway hyperresponsiveness to both histamine and carbachol in allergic sheep. Pirodomast was being investigated for use in asthma and allergic rhinitis.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Effect of inhibitors of leukotriene and/or platelet activating factor on killed H. influenzae induced experimental otitis media with effusion. | 2004-01 |
|
| Tryptase-induced airway microvascular leakage in guinea pigs: involvement of tachykinins and leukotrienes. | 2001-05-11 |
|
| Sch 37224, an experimental antiallergy compound, inhibits the neuropeptide component of hyperventilation- and nicotine-induced bronchoconstriction in guinea pigs. | 1997-01 |
|
| Effect of leukotriene inhibitor on otoacoustic emissions in salicylate ototoxicity. | 1996-09 |
|
| Effect of leukotriene inhibitor on cochlear blood flow in salicylate ototoxicity. | 1995-03 |
|
| Effect of SCH 37224 on anti-IgE-induced formation of sulfidopeptide leukotrienes in human lung parenchyma. | 1992-08-14 |
|
| Anaphylactic challenge causes eosinophil accumulation in bronchoalveolar lavage fluid of guinea pigs. Modulation by betamethasone, phenidone, indomethacin, WEB 2086, and a novel antiallergy agent, SCH 37224. | 1990-09 |
|
| Antiallergy activity of Sch 37224, a new inhibitor of leukotriene formation. | 1988-12 |
|
| A leukotriene and thromboxane inhibitor (Sch 37224) blocks antigen-induced immediate and late responses and airway hyperresponsiveness in allergic sheep. | 1988-12 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 09:43:15 GMT 2025
by
admin
on
Wed Apr 02 09:43:15 GMT 2025
|
| Record UNII |
1S2EOV9V3Z
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C29712
Created by
admin on Wed Apr 02 09:43:15 GMT 2025 , Edited by admin on Wed Apr 02 09:43:15 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C82230
Created by
admin on Wed Apr 02 09:43:15 GMT 2025 , Edited by admin on Wed Apr 02 09:43:15 GMT 2025
|
PRIMARY | |||
|
6669
Created by
admin on Wed Apr 02 09:43:15 GMT 2025 , Edited by admin on Wed Apr 02 09:43:15 GMT 2025
|
PRIMARY | |||
|
54680204
Created by
admin on Wed Apr 02 09:43:15 GMT 2025 , Edited by admin on Wed Apr 02 09:43:15 GMT 2025
|
PRIMARY | |||
|
DTXSID20148498
Created by
admin on Wed Apr 02 09:43:15 GMT 2025 , Edited by admin on Wed Apr 02 09:43:15 GMT 2025
|
PRIMARY | |||
|
CHEMBL2105217
Created by
admin on Wed Apr 02 09:43:15 GMT 2025 , Edited by admin on Wed Apr 02 09:43:15 GMT 2025
|
PRIMARY | |||
|
100000081695
Created by
admin on Wed Apr 02 09:43:15 GMT 2025 , Edited by admin on Wed Apr 02 09:43:15 GMT 2025
|
PRIMARY | |||
|
1S2EOV9V3Z
Created by
admin on Wed Apr 02 09:43:15 GMT 2025 , Edited by admin on Wed Apr 02 09:43:15 GMT 2025
|
PRIMARY | |||
|
108310-20-9
Created by
admin on Wed Apr 02 09:43:15 GMT 2025 , Edited by admin on Wed Apr 02 09:43:15 GMT 2025
|
PRIMARY | |||
|
SUB09929MIG
Created by
admin on Wed Apr 02 09:43:15 GMT 2025 , Edited by admin on Wed Apr 02 09:43:15 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|